CVE:BRM BioRem (BRM) Stock Price, News & Analysis C$3.69 +0.06 (+1.65%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChart About BioRem Stock (CVE:BRM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioRem alerts:Sign Up Key Stats Today's RangeC$3.63▼C$3.9050-Day RangeC$2.98▼C$3.8952-Week RangeC$1.87▼C$3.95Volume59,641 shsAverage Volume26,196 shsMarket CapitalizationC$59.91 millionP/E Ratio10.98Dividend Yield6.47%Price TargetN/AConsensus RatingN/A Company Overview BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada. Read More Receive BRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioRem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BRM Stock News HeadlinesAndina, BioRem, Cavvy at 52-Week High on NewsMay 14, 2026 | baystreet.caBiorem Reports $65.3 Million Order BacklogApril 20, 2026 | finance.yahoo.comThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.August 24 at 1:00 AM | Chaikin Analytics (Ad)BioRem Inc.'s (CVE:BRM) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?October 25, 2025 | finance.yahoo.comBiorem Reports Record Revenues and Earnings before tax for 2024 and Again Reports Record Order BacklogApril 17, 2025 | finance.yahoo.comBRM:CA BioRem Inc.March 20, 2025 | seekingalpha.comAre Robust Financials Driving The Recent Rally In BioRem Inc.'s (CVE:BRM) Stock?February 17, 2025 | finance.yahoo.comBIOREM Announces Orders Totalling $8 Million and Order Backlog of $60.5 MillionFebruary 11, 2025 | finance.yahoo.comSee More Headlines BRM Stock Analysis - Frequently Asked Questions How have BRM shares performed this year? BioRem's stock was trading at C$2.70 on January 1st, 2026. Since then, BRM stock has increased by 41.5% and is now trading at C$3.82. How were BioRem's earnings last quarter? BioRem Inc. (CVE:BRM) announced its earnings results on Wednesday, November, 6th. The company reported $0.12 EPS for the quarter. BioRem had a net margin of 12.26% and a trailing twelve-month return on equity of 41.45%. How do I buy shares of BioRem? Shares of BRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of BioRem own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioRem investors own include TVA Group (TVA.B), Questor Technology (QST), AutoZone (AZO), Cadence Design Systems (CDNS), FormFactor (FORM), Intel (INTC) and Company Calendar Last Earnings11/06/2024Today8/24/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorIndustrials Industry Commercial Services & Supplies Sub-IndustryN/A Current SymbolCVE:BRM CIKN/A Webwww.biorem.biz Phone+1-519-7679100FaxN/AEmployees34,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.34 Trailing P/E Ratio10.98 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$5.40 million Net Margins12.26% Pretax MarginN/A Return on Equity41.45% Return on Assets14.61% Debt Debt-to-Equity Ratio14.17 Current Ratio2.04 Quick Ratio1.08 Sales & Book Value Annual SalesC$50.70 million Price / Sales1.18 Cash FlowC$1.00 per share Price / Cash Flow3.70 Book ValueC$1.09 per share Price / Book3.40Miscellaneous Outstanding Shares16,235,000Free FloatN/AMarket CapC$59.91 million OptionableNot Optionable Beta0.81 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (CVE:BRM) was last updated on 8/24/2026 by MarketBeat.com Staff. From Our PartnersIn 2022, every resident of this state received $3,284Since 1982, Alaska has paid every resident an annual check from its oil wealth, $3,284 in 2022 alone, funded e...Freedom Financial | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredBuy These Stocks Before August 31stKeith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...TradeSmith | SponsoredThe dollar just brokeBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...Porter & Company | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRem With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
